The company acquired a companion animals laboratory and continues its strategy to diversify its portfolio, venture into other species and further expand into new markets.
Biogénesis Bagó, a biotechnology company specialized in animal health, added a new milestone to the growth they have experienced in the last few years with the announcement of the acquisition of Laboratorio Mayors, an animal health company with more than three decades of experience and prestige in the Latin American pet’s market.
The incorporation of this renowned laboratory allows Biogénesis Bagó to complement its current portfolio of products for pets – mainly focused on vaccines- with a set of pharmaceutical products that includes anti-arthritic, anti-parasiticides, gastric protectors and dermatological solutions, continuing to provide veterinarians, distributors, and responsible tutors with the best solutions in terms of health for dogs and cats.
This acquisition will also give the company access to new markets, as the products will be sold in 16 countries in Latin America and the Middle East, and is aligned with company’s business strategy that seeks to place Biogénesis Bagó among the top 20 animal health companies in the world.
"We are very excited about this commitment to one of the fastest growing sectors in animal health. Through it, we seek to provide veterinarians with new and better solutions. Definitely this acquisition will strengthen our strategy of diversification of products, species and markets", said Esteban Turic, CEO of Biogénesis Bagó.
The pet market is experiencing an exponential development at a global level. In fact, it represents the most important driver of growth within the animal health industry. Latin America is the region with the largest number of families with pets, since 80% of households have at least one of them. Therefore, it is essential for the company to take care of the health of dogs and cats to guarantee not only their well-being but also the health of the rest of the family members.
With this investment, Biogénesis Bagó positions itself as an increasingly important player in the companion animal market, consolidating itself as a company in constant evolution, deepening its commitment to animal health and continuing to work under the "One Health" approach to provide comprehensive and world class solutions to veterinary professionals according to the growing demands of the market.